In the latest trading session, DaVita HealthCare (DVA) closed at $179.25, marking a +1.26% move from

DaVita is rated Buy with a $220 12-month price target, offering 22% upside from current levels. Desp

DaVita gains from IKC growth, improving treatment economics and stronger formulary adoption, but pay

Patients encouraged to confirm treatment schedules, prepare emergency supplies and contact DaVita fo

Michael Burry calls Anthropic's valuation a 'bubble,' noting it could buy 78 profitable

American Express is the last remaining credit card stock in Berkshire's portfolio. The New York Time

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $178.69, denoting a +1.33

DaVita reported double-digit EPS growth in the second quarter. Berkshire Hathaway owns roughly 45% o

The latest trading day saw DaVita HealthCare (DVA) settling at $174.67, representing a -4.62% change

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

With AI companies—and related chip stocks—driving much of the market's performance this year, it's u

DaVita HealthCare (DVA) closed the most recent trading day at $193.86, moving +1.55% from the previo

President Donald Trump has disclosed over 20,000 stock trades made over the past 12 months. The trad

The investment portfolio of President Donald Trump and Berkshire Hathaway have 17 stocks in common.

On September 14, 2026, DaVita Inc (DVA) shares rose 4.3% to $189.32, reflecting strong momentum as t

DVA gains from expanding value-based kidney care, improving dialysis volumes and clinical innovation

A federal court preliminarily approves a class action settlement for 2.3 million patients affected b

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?

Investors need to pay close attention to DVA stock based on the movements in the options market late

An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient an

Berkshire slashed its Capital One stake by 58%, among its largest cuts, despite the stock's top

In fact, it's a healthcare company. It is a strong player in its chosen niche.

DaVita expands its Humana partnership to earlier-stage kidney disease, bringing value-based care to

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the

Launched July 1, this partnership builds on the organizations' long-standing collaboration in en

More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducin

TD Cowen analyst Ryan Langston upgrades DaVita (NYSE:DVA) from Hold to Buy and lowers the price t

US payrolls shrank by 23K in July. Here is how weak jobs data sparked gains for tech, gold, and top

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and lowers the

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP

U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 reve

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price

DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus es

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and raises the price targe

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Top Wall Street analysts upgraded several top stocks. See all changes and ratings on Benzinga's

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised

Deutsche Bank analyst Pito Chickering upgrades DaVita (NYSE:DVA) from Hold to Buy and raises the

DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus es

The latest 13F filing from Berkshire Hathaway reveals some of the final position changes made by War

Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East

DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 gu